{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:57:18Z","timestamp":1792177038338,"version":"4.4.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>This study aimed to evaluate the efficacy and safety of mesenchymal stem cell (MSC) therapy for osteoarthritis (OA) through a systematic review and meta-analysis of randomized controlled trials (RCTs), focusing on patient-reported pain and functional outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted across multiple databases including PubMed, Embase, Web of Science, and Cochrane Library from inception to 1st October 2025. RCTs comparing intra-articular MSC injections with control interventions (placebo, hyaluronic acid, or other active treatments) in adult OA patients were included. Primary outcomes were changes in pain intensity measured by Visual Analog Scale (VAS) and functional improvement assessed by International Knee Documentation Committee (IKDC) score. Secondary outcomes included Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Lequesne index, Lysholm score, and Tegner activity scale. Data were pooled using random-effects models and expressed as mean differences (MD) with 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven RCTs involving 811 patients were included. MSC therapy demonstrated significant reduction in VAS pain scores compared to controls (MD -4.08, 95% CI -5.56 to \u22122.61, p &amp;lt; 0.00001), with the most pronounced effects at 24-month follow-up (MD -3.31, 95% CI -5.18 to \u22121.44, p = 0.0005). Significant improvements were observed in IKDC scores (MD 2.88, 95% CI 0.28 to 5.47, p = 0.03), WOMAC index (MD -11.05, 95% CI -15.97 to \u22126.14, p &amp;lt; 0.0001), Lequesne index (MD -5.32, 95% CI -5.91 to \u22124.74, p &amp;lt; 0.00001), Lysholm score (MD 5.07, 95% CI 1.86 to 8.29, p = 0.002), and Tegner activity scale (MD 0.44, 95% CI 0.25 to 0.62, p &amp;lt; 0.00001). The therapeutic effects showed a time-dependent pattern, with maximal benefits observed at 24-month follow-up across all outcome measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intra-articular MSC injection is an effective treatment for osteoarthritis, providing significant and durable improvements in pain relief, functional recovery, and activity levels up to 24 months post-treatment. The time-dependent nature of clinical benefits suggests a potential disease-modifying mechanism of action. MSC therapy represents a promising regenerative approach for OA management that warrants further investigation in large-scale trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2025.1746471","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:41:33Z","timestamp":1767681693000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery"],"prefix":"10.3389","volume":"13","author":[{"given":"Jincheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renshou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00402-014-2136-z","article-title":"Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study","volume":"135","author":"Akgun","year":"2015","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-025-04252-2","article-title":"Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Cao","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13018-024-04846-1","article-title":"Transplantation of three mesenchymal stem cells for knee osteoarthritis, which cell and type are more beneficial? a systematic review and network meta-analysis","volume":"19","author":"Chen","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"20502","DOI":"10.1021\/acsnano.4c16918","article-title":"MXene-Based cartilage-adhesive microspheres for photothermal-controlled hydrophobic drug release and mesenchymal stem cell delivery in osteoarthritis","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"key":"B5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/BOR.0b013e32835aa28d","article-title":"Stem cell-based therapies for osteoarthritis: challenges and opportunities","volume":"25","author":"Diekman","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.3390\/ijms24076405","article-title":"Knee osteoarthritis: epidemiology, pathogenesis, and mesenchymal stem cells: what else is new? An update","volume":"24","author":"Giorgino","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40259-018-0276-3","article-title":"Tissue engineering in osteoarthritis: current status and prospect of mesenchymal stem cell therapy","volume":"32","author":"Im","year":"2018","journal-title":"BioDrugs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.3390\/ijms22052619","article-title":"Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2000082","DOI":"10.1002\/biot.202000082","article-title":"Mesenchymal stem cell-derived exosomes for effective cartilage tissue repair and treatment of osteoarthritis","volume":"15","author":"Kim","year":"2020","journal-title":"Biotechnol. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.knee.2012.04.001","article-title":"Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis","volume":"19","author":"Koh","year":"2012","journal-title":"Knee"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.arthro.2014.05.036","article-title":"Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study","volume":"30","author":"Koh","year":"2014","journal-title":"Arthroscopy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/sctm.18-0122","article-title":"Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial","volume":"8","author":"Lee","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s13238-021-00860-9","article-title":"Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis","volume":"13","author":"Lei","year":"2022","journal-title":"Protein Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/011574888X338318241213055616","article-title":"Intraarticular injection of stem cell and related exosome targeting synovial macrophages in osteoarthritis","volume":"20","author":"Li","year":"2025","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"B15","first-page":"1","article-title":"Arthroscopic microfracture surgery combined with autologous bone marrow mesenchymal stem cells transplant in the treatment of knee cartilage defect","volume":"9","author":"Liang","year":"2015","journal-title":"Chin. J. Mod. Drug Appl."},{"key":"B16","first-page":"28","article-title":"Effectiveness of autologous bone marrow mesenchymal stem cell transplant for knee osteoarthritis","volume":"5","author":"Lv","year":"2015","journal-title":"Chin. J. Cell Stem Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/genes13060949","article-title":"Mesenchymal stem cell mechanisms of action and clinical effects in osteoarthritis: a narrative review","volume":"13","author":"Molnar","year":"2022","journal-title":"Genes (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1177\/0363546509359067","article-title":"Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study","volume":"38","author":"Nejadnik","year":"2010","journal-title":"Am. J. Sports Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/stem.3139","article-title":"Stem cell-directed therapies for osteoarthritis: the promise and the practice","volume":"38","author":"Ng","year":"2020","journal-title":"Stem Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2300315","DOI":"10.1002\/adhm.202300315","article-title":"Treatment with mesenchymal stem cell-derived nanovesicle-containing gelatin methacryloyl hydrogels alleviates osteoarthritis by modulating chondrogenesis and macrophage polarization","volume":"12","author":"Pang","year":"2023","journal-title":"Adv. Healthc. Mater"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1007\/s00167-023-07575-w","article-title":"Mesenchymal stem cell implantation provides short-term clinical improvement and satisfactory cartilage restoration in patients with knee osteoarthritis but the evidence is limited: a systematic review performed by the early-osteoarthritis group of ESSKA-european knee associates section","volume":"31","author":"Razak","year":"2023","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/cells12101421","article-title":"Therapeutic perspectives for inflammation and senescence in osteoarthritis using mesenchymal stem cells, mesenchymal stem cell-derived extracellular vesicles and senolytic agents","volume":"12","author":"Rizzo","year":"2023","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.pmrj.2015.01.023","article-title":"Stem cell therapies for treatment of cartilage and bone disorders: osteoarthritis, avascular necrosis, and non-union fractures","volume":"7","author":"Sampson","year":"2015","journal-title":"PM R."},{"key":"B24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.arthro.2012.12.008","article-title":"Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial","volume":"29","author":"Saw","year":"2013","journal-title":"Arthroscopy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1186\/s12967-024-05814-3","article-title":"Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence","volume":"22","author":"Sun","year":"2024","journal-title":"J. Transl. Med."},{"key":"B26","first-page":"35","article-title":"Therapeutic effect of arthroscopy combined with autologous bone marrow stem cell grafting on knee osteoarthritis","volume":"25","author":"Tan","year":"2013","journal-title":"J. Traditional"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3892\/ijmm.2023.5326","article-title":"Single-cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review)","volume":"53","author":"Tan","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9149","DOI":"10.3390\/ijms25179149","article-title":"Mesenchymal stem cell-derived exosomes as a treatment option for osteoarthritis","volume":"25","author":"Vadhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2106\/JBJS.M.00058","article-title":"Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study","volume":"96","author":"Vangsness","year":"2014","journal-title":"J. Bone Jt. Surg. Am."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","article-title":"Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial","volume":"99","author":"Vega","year":"2015","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2147\/JIR.S406298","article-title":"Magnoflorine ameliorates collagen-induced arthritis by suppressing the inflammation response via the NF-\u03baB\/MAPK signaling pathways","volume":"16","author":"Wang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/ijms24010059","article-title":"Intra-articular mesenchymal stem cell injection for knee osteoarthritis: mechanisms and clinical evidence","volume":"24","author":"Wei","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"174865","DOI":"10.1016\/j.ejphar.2022.174865","article-title":"Urolithin A attenuates RANKL-induced osteoclastogenesis by co-regulating the p38 MAPK and Nrf2 signaling pathway","volume":"921","author":"Wei","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.arthro.2013.09.074","article-title":"Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years' follow-up","volume":"29","author":"Wong","year":"2013","journal-title":"Arthroscopy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12951-024-02765-1","article-title":"Stem cell recruitment polypeptide hydrogel microcarriers with exosome delivery for osteoarthritis treatment","volume":"22","author":"Yang","year":"","journal-title":"J. Nanobiotechnology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/stcltm\/szae031","article-title":"Effects of human umbilical cord mesenchymal stem cell-derived exosomes in the rat osteoarthritis models","volume":"13","author":"Yang","year":"","journal-title":"Stem Cells Transl. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3892\/ijmm.2022.5118","article-title":"Transforming growth factor-\u03b2 family and stem cell-derived exosome therapeutic treatment in osteoarthritis (Review)","volume":"49","author":"Yoo","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"eabk0011","DOI":"10.1126\/sciadv.abk0011","article-title":"Stem cell-homing hydrogel-based miR-29b-5p delivery promotes cartilage regeneration by suppressing senescence in an osteoarthritis rat model","volume":"8","author":"Zhu","year":"2022","journal-title":"Sci. Adv."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1746471\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:41:43Z","timestamp":1767681703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1746471\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":39,"alternative-id":["10.3389\/fcell.2025.1746471"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1746471","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"1746471"}}